...
首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Phosphatidylcholine does not protect rats against 5-fluorouracil/folinic acid-induced damage of the intestinal luminal mucosa
【24h】

Phosphatidylcholine does not protect rats against 5-fluorouracil/folinic acid-induced damage of the intestinal luminal mucosa

机译:磷脂酰胆碱不能保护大鼠免受5-氟尿嘧啶/亚叶酸诱导的肠腔粘膜损害

获取原文
获取原文并翻译 | 示例

摘要

Purpose: The study was performed to evaluate the ability of phosphatidylcholine (PPC) to modulate the toxicity of 5-fluorouracil/folinic acid (5-FU/FA) in rats. Methods: Twenty-eight female Wistar rats were divided into four series, each consisting of 6–8 animals and administered 0.5 ml isotonic solution i.v. once a day. The series were as follows: 1) saline; 2) 20 mg 5-FU + 4 mg FA; 3) 30 mg 5-FU + 6 mg FA; 4) 2 weeks daily orally 50 mg PPC/kg body weight (b.w.), on day 12, 30 mg 5-FU + 6 mg FA. As an indicator of membrane luminal impairment, 72 h after an i.v. administration, peptidase activities were measured by using an in situ perfusion model. Results: The i.v. application of 5-FU/FA causes a clear reduction of enzyme activities in comparison to the control group. Conclusions: In investigations with rats, we have shown that a low concentration of oral PPC (50 mg/kg b.w.) cannot protect the luminal mucosa membrane from being injured by the enterotoxic action of 5-FU/FA.
机译:目的:进行这项研究以评估磷脂酰胆碱(PPC)调节5-氟尿嘧啶/亚叶酸(5-FU / FA)对大鼠的毒性的能力。方法:将28只Wistar雌性大鼠分为四个系列,每组由6-8只动物组成,并静脉内注射0.5 ml等渗溶液。一天一次。系列如下:1)盐水; 2)20 mg 5-FU + 4 mg FA; 3)30 mg 5-FU + 6 mg FA; 4)每天2周,第12天口服50 mg PPC / kg体重(b.w.),30 mg 5-FU + 6 mg FA。静脉内注射72小时后,作为膜腔损伤的指标。给药时,肽酶活性通过使用原位灌注模型测量。结果:i.v。与对照组相比,施用5-FU / FA会明显降低酶的活性。结论:在对大鼠的调查中,我们发现低浓度的口服PPC(50 mg / kg b.w.)不能保护腔粘膜免受5-FU / FA的肠毒性作用的伤害。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号